1 Econoqualimetrics Edward Broughton, PhD., MPH Senior Economic Analyst, USAID Health Care Improvement Project, EnCompass,

Slides:



Advertisements
Similar presentations
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
Advertisements

ECONOMIC EVALUATION WHY DO YOU NEED TO BOTHER? JUDITH BOSMANS.
Leading Change From the Front Line In Afghanistan USAID Health Care Improvement (HCI) Project University Research Co., LLC Center for Human Services.
REDUCING MATERNAL AND NEONATAL MORTALITY IN MOZAMBIQUE THE CHALLENGE IN THE NEW MILLENIUM.
1 Better health processes and outcomes: How do we get there? Maina Boucar, MD, MPH USAID – Applying Science to Strengthen and Improve Systems Regional.
1 Are you sure your improvements are cost-effective? Edward Broughton, PhD, MPH, PT University Research Co. April 11, 2014
ADDING IT UP The costs and benefits of investing in family planning and maternal and newborn health.
1 Economic Analysis of a Maternal and Neonatal Health Improvement Intervention in Niger Edward Broughton, PhD, MPH EnCompass, LLC
HERU is supported by the Chief Scientist Office of the Scottish Government Health Directorates and the University of Aberdeen. The author accepts full.
Neonatal Mortality in Ghana Keeps MDG 4 at the Crossroads.
Saving Newborn Lives: The Global Perspective Anne Tinker Director Saving Newborn Lives Initiative Save the Children Federation Washington, DC, USA World.
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pricing (VBP) Penny Watson 1, Alan Brennan 1 1 Health Economics and Decision.
Incorporating considerations about equity in policy briefs What factors are likely to be associated with disadvantage? Are there plausible reasons for.
Alternative antiretroviral monitoring strategies for HIV-infected patients in resource-limited settings: Opportunities to save more lives? R Scott Braithwaite,
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
Health care decision making Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, June 2008.
Cost-effectiveness Analysis: A practical primer Eran Bendavid.
A tisket, a tasket, is MNCH in your benefits basket? March 2, 2015.
Who is involved in making NICE guidance recommendations and what evidence do they look at? Jane Cowl, Senior Public Involvement Adviser Tommy Wilkinson,
Chapter 4: Economic Efficiency and Cost Benefit Analysis 1.Economic Efficiency 2.Cost Benefit Analysis.
Assessing cost-effectiveness – what is an ICER?- Incremental analysis
Ministry of Health Syed Anwar Mahmood Federal Secretary (Health) Government of Pakistan Saving Children’s lives through Community based Interventions.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
1 Cost-effectiveness of improving medical services in low-resource settings Edward Broughton, PhD, MPH, PT University Research Co. May 21, 2014
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
BIOE 301 Lecture Thirteen. HIV/AIDS Vaccine Update.
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
The State of the World’s Children 2008 Themes Child Survival: Where we stand Lessons learned from evolving health- care systems and practices Community.
Integrated Care What do we stand to gain? Kim Sutherland, PhD Director, System and Thematic Reports 22 November 2014.
Overcoming provider barriers to introduction and sustainability of AMTSL at facilities Susheela M. Engelbrecht PATH / Oxytocin Initiative.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Selecting priorities for MNCH Prioritizing activities of identified problems or challenges.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
Western NSW Integrated Care Strategy To transform existing services into an integrated Western NSW system of care that is tailored to the needs of our.
1 Challenges and successes in maintaining gains in quality of care and institutionalizing quality improvement in Niger Maina Boucar, MD, MPH USAID - Health.
Country Team Action Plan Cambodia. Tracks 1 & 2 2 Where are we now? Key program/country needs and challenges –MMR of 472 / 100,000 hasn’t budged in 15.
Make Nutrition Services Count: Cost-Effectiveness Research & Outcomes Research.
POSTPARTUM HEMORRHAGE PREVENTION BENIN EXPERIENCE Prof. R-X PERRIN, Prof. Ag. S. ADISSO, Dr. S. ABOUDOU Addis – Ababa, 2011.
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.
Inaugural Conference of the African Health Economics and Policy Association (AfHEA) Accra - Ghana, 10th - 12th March 2009 COST EFFECTIVENESS ANALYSIS OF.
WHAT IS HEALTH ECONOMICS? ACCOUNTANTS CARE ONLY ABOUT $$$$$$$$$$ ACCOUNTANTS CARE ONLY ABOUT $$$$$$$$$$ PHYSICIANS CARE ONLY ABOUT PATIENTS…… PHYSICIANS.
The Role of Perspective in Economic Evaluation for Cancer Prevention Steven Kymes, Ph.D. Research Associate Professor of Ophthalmology And Visual Sciences.
Promoting Quality Care Dr. Gwen Hollaar. Introduction We all want quality in health care –Communities –Patients –Health Care Workers –Managers –MOH /
Health Status Indicators: Life Expectancy
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Health Economic Course Series
Improving the Quality of Care of Sick Children in District Hospitals in Kenya: A Cost-Effectiveness Analysis Barasa W. E, Ayieko P, Cleary S, English M.
International SBCC Summit
Who am I ?Who am I ? Nam Nguyen-Hoang – Welcome To Life Project Coordinator in Khanh Hoa province, Vietnam. Background in Health Education and Behavior.
BIOE 301 Lecture Sixteen. Review of Lectures What is the goal of cancer screening? Successful cancer screening examples? Can screening hurt more.
Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.
Concepts of Primary health care Ass.Prof:Dr:Essmat Gemaey
Presentor : Maher shahid (Post RN, BScN 1 ST sem) Subject: Culture Health Society Faculty: Ramesh kumar Date: 16,Nov, 2015 NEWLIFE COLLEGE OF NURSING.
Evaluating sustainability of programs in developing countries: What do we measure and how? LYNNE MILLER FRANCO, Vice President Technical Assistance and.
1 Is it cost-effective to kill patients? Edward Broughton, PhD., MPH Director, USAID Health Care Improvement Project, University Research Co.
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment in Postnatal Patients.
Supporting measurement & improvement of primary health care (PHC) at the facility and community levels Dr. Jennifer Adams, Deputy Assistant Administrator,
Humanizing and Transforming the Maternal & Neonatal Health Care in Mozambique: The Model Maternity Initiative Maria da Luz Velho Vaz, MD, MPH Maternal.
Date of download: 6/2/2016 From: New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Ann Intern Med. 2012;156(4):
1 Edward Broughton, PhD., MPH Director of Research and Evaluation, USAID Health Care Improvement Project, University Research Co., LLC
Burden of Disease and Health Economics: Friends or Foes?
Cost effectiveness Analysis: Valuing Health; Valuing Research!
HEALTH ECONOMICS BASICS
Reducing global mortality of children and newborns
Journal Club Notes.
Sergio Bautista-Arredondo National Institute of Public Health Mexico
Rita Faria, MSc Centre for Health Economics University of York, UK
Presentation transcript:

1 Econoqualimetrics Edward Broughton, PhD., MPH Senior Economic Analyst, USAID Health Care Improvement Project, EnCompass,

USAID HEALTH CARE IMPROVEMENT PROJECT Objectives What are the quality improvement interventions that we evaluate? What is cost-effectiveness analysis? Why do we do CEAs on QI interventions? How do you do CEAs of QI interventions? How do you interpret the results? What do you do with the results of a CEA?

USAID HEALTH CARE IMPROVEMENT PROJECT What are the quality improvement interventions that we evaluate? Improvement collaboratives Standards-based management Client-oriented, provider-efficient (COPE) Continuous quality improvement others

USAID HEALTH CARE IMPROVEMENT PROJECT EONC QI intervention in Niger Essential Obstetric and newborn care Program to address poor birth outcomes for mothers and children Coordinated and supported multiple facility-based teams to overcome barriers to implementation of interventions to reduce PPH and maternal and newborn mortality Teams worked on common set of evidence-based care practices, monitored indicators, and met regularly to share successful changes Active management of the third stage of labor (AMTSL) and immediate essential newborn care (ENC) 25 reference hospitals in 7 of Niger’s 8 regions in Expanded to 8 primary care maternities.

USAID HEALTH CARE IMPROVEMENT PROJECT What is cost-effectiveness analysis? A way to measure efficiency of an intervention Cost-effectiveness = costs ÷ effects Cost-effectiveness ANALYSIS is the cost-effectiveness of one intervention relative to a baseline One of many forms of economic analysis. Others include cost-minimization, cost-utility analysis and cost- benefit analysis

USAID HEALTH CARE IMPROVEMENT PROJECT Why do cost-effectiveness analysis of QI programs? Compare the QI intervention to doing nothing Compare one QI intervention to another Compare a QI intervention to another health intervention Determine what the biggest contribution to the cost- effectiveness of a program is Determine whether a program is affordable / sustainable

USAID HEALTH CARE IMPROVEMENT PROJECT How to do a CEA There is a flu epidemic at and there is a 100% certainty that you will contract the disease Cost of the flu vaccine (100% effective) is $15 Treatment of a case of flu costs $10 Cost of flu vaccine strategy is: $15 - $10 = $ 5

USAID HEALTH CARE IMPROVEMENT PROJECT Is it cost-effective? Incremental cost-effectiveness ratio (ICER) = difference in costs / difference in effects ICER = ($ 15 – 10) / (1 – 0) = $5 / flu case averted What if the flu vaccine cost $ 5 ? ICER = ($ 5 – 10) / (1 – 0) = – $ 5 /per flu case averted

USAID HEALTH CARE IMPROVEMENT PROJECT CEA of EONC QI intervention in Niger Answers the question of what are the effects of the intervention on mothers and newborns Cost-effectiveness = Cost of the intervention per outcome (birth) CEA is cost-effectiveness after the intervention relative to the cost- effectiveness before the intervention Active management of the third stage of labor (AMTSL) and immediate essential newborn care (ENC) 25 reference hospitals in 7 of Niger’s 8 regions in Expanded to 8 primary care maternities.

USAID HEALTH CARE IMPROVEMENT PROJECT Defining the study What is the specific question we are asking? From whose perspective are we asking it? What is the time-frame? What are the outcomes we are considering?

USAID HEALTH CARE IMPROVEMENT PROJECT Data Costs –Costs of the intervention: HCI/USAID, MOH, (patients) –Change in costs of services (deliveries) –(costs to the MOH if they were doing the intervention) Effectiveness –Process measures Compliance with treatment standards –Patient outcomes PPH, deaths averted –Composite measures DALYs, QALYs

USAID HEALTH CARE IMPROVEMENT PROJECT Models

USAID HEALTH CARE IMPROVEMENT PROJECT Key results: : Cost effectiveness analysis of the EONC QI intervention in Niger Therefore the MOH implementing the improvement collaborative improves service delivery and maternal outcomes AND saves money Total cost of QI intervention w HCI and MOH: $ 843,000 or $ 9.45 per delivery Incremental total cost: $ 217,000 or $ 2.43 per delivery Total cost of MOH alone: $ 404,000 or $ 4.50 per delivery Incremental cost: -$ 152,000 or -$ 1.70 per delivery Average cost per delivery: Before QI: $ 35After QI: $ 28 Incremental cost-effectiveness With MoH & HCI & development costs W. costs for MoH to implement program Estimate ($) Per PPH averted Per additional mother receiving AMTSL Per child receiving essential neonatal care Per DALY averted

USAID HEALTH CARE IMPROVEMENT PROJECT Cost effectiveness plane 14 Higher cost Lower cost More effective Less effective Willingness-to-pay threshold $3.17 -$2.23

USAID HEALTH CARE IMPROVEMENT PROJECT Willingness to pay For the individual: how much would you be willing to pay for good health / avoid bad health? For society: how much have decisionmakers decided to pay for good health / avoid bad health? –UK threshold approx £35,000 (US$55,650) –Australia and NZ about the same –Developing countries: ? Affordability –Use of league tables

USAID HEALTH CARE IMPROVEMENT PROJECT Cost effectiveness plane 16 Higher cost Lower cost More effective Less effective Willingness-to-pay threshold Accept Reject Accept Reject Accept (?)

USAID HEALTH CARE IMPROVEMENT PROJECT Interpretation of results Intervention cost $843,000 but saved $626,000 therefore the net cost was $217,000 (or $2.43/delivery) The relative cost-effectiveness (ICER) is $ 3.17 per DALY averted if HCI does the intervention or … …about —$2.23 per DALY averted if MOH does the intervention

USAID HEALTH CARE IMPROVEMENT PROJECT But….. Efficiency is only one criteria for health resource allocation decisions We should consider equity We should consider affordability We should consider sustainability

USAID HEALTH CARE IMPROVEMENT PROJECT Mini-Exam Which of the following is true?: A.0.1 QALYs is better health than 0.1 DALYs B.0.1 DALYs is better health than 0.1 QALYs C.0.1 QALYs is roughly equivalent health to 0.1 DALYs D.Not enough information to decide If comparing your health program to a baseline, which of the following is true?: A.negative incremental cost-effectiveness ratio is better than positive B.Positive incremental cost-effectiveness ratio is better than negative C.The sign on an incremental cost-effectiveness ratio is irrelevant D.Not enough information to decide

USAID HEALTH CARE IMPROVEMENT PROJECT Mini-Exam Which of the following is true?: B.0.1 DALYs is better health than 0.1 QALYs If comparing your health program to a baseline, which of the following is true?: A.negative incremental cost-effectiveness ratio is better than positive